Skip to Content
U.S. National Institutes of Health
Last Updated: 03/05/10

Strategy Group Meeting Agenda

November 10, 2003

Colon Cancer Working Group Progress Report Dr. Kim Jessup
Breast Cancer Working Group Final Report
  • model building process
  • clinical trial design

Discussion of Breast Cancer Working Group

  • analysis of process
  • identification of markers/technologies and interactions with industry
Dr. Sheila Taube
Current NCI industry assistance mechanisms

How can the NCI facilitate evaluation of promising technologies/markers?

  • identification of companies
  • infrastructure needs

Next set of critical clinical questions/action plan

Dr. Sherry Ansher